The Core FM system offers easy-to-use advanced physiology modalities. Core FM provides hyperemia-free iFR measurement in as few as five heartbeats with both mobile and bedside configurations. You can easily switch between iFR and FFR measurement with a single touch to the screen. This system is designed for simplifying physiology, providing choice, and building evidence.
Κάνοντας κλικ στον σύνδεσμο, θα φύγετε από τον επίσημο ιστότοπο της Philips Electronics Ltd. ("Philips"). Τυχόν σύνδεσμοι προς ιστότοπους τρίτων που ενδέχεται να εμφανίζονται σε αυτόν τον ιστότοπο παρέχονται μόνο για τη διευκόλυνσή σας και σε καμία περίπτωση δεν αντιπροσωπεύουν οποιαδήποτε σχέση ή έγκριση των πληροφοριών που παρέχονται σε αυτούς τους συνδεδεμένους ιστότοπους. Η Philips δεν προβαίνει σε δηλώσεις ή εγγυήσεις κανενός είδους σχετικά με ιστότοπους τρίτων ή τις πληροφορίες που περιέχονται σε αυτούς.
For immediate technical support, please use the phone number below.
Philips Greece
+30 210 6162 000
Media Gallery
Features
iFR modality
Clinical progress
The iFR modality has been studied in over 9,000 patients, and large iFR outcome trials have enrolled 5,000 patients.¹ Additionally, numerous prospective iFR studies have been published in peer-reviewed journals showing its significance in assisting lesion assessment.
Clinical progress
The iFR modality has been studied in over 9,000 patients, and large iFR outcome trials have enrolled 5,000 patients.¹ Additionally, numerous prospective iFR studies have been published in peer-reviewed journals showing its significance in assisting lesion assessment.
Clinical progress
The iFR modality has been studied in over 9,000 patients, and large iFR outcome trials have enrolled 5,000 patients.¹ Additionally, numerous prospective iFR studies have been published in peer-reviewed journals showing its significance in assisting lesion assessment.
The iFR modality has been studied in over 9,000 patients, and large iFR outcome trials have enrolled 5,000 patients.¹ Additionally, numerous prospective iFR studies have been published in peer-reviewed journals showing its significance in assisting lesion assessment.
iFR Scout
iFR Scout Pullback technology
iFR Scout pullback technology provides the physiologic profile of the entire vessel, helping you make informed treatment decisions when you encounter serial lesions or diffuse disease. Hyperemia-free iFR Scout makes assessing physiology before, during, and after your procedure easier.
iFR Scout Pullback technology
iFR Scout pullback technology provides the physiologic profile of the entire vessel, helping you make informed treatment decisions when you encounter serial lesions or diffuse disease. Hyperemia-free iFR Scout makes assessing physiology before, during, and after your procedure easier.
iFR Scout Pullback technology
iFR Scout pullback technology provides the physiologic profile of the entire vessel, helping you make informed treatment decisions when you encounter serial lesions or diffuse disease. Hyperemia-free iFR Scout makes assessing physiology before, during, and after your procedure easier.
iFR Scout pullback technology provides the physiologic profile of the entire vessel, helping you make informed treatment decisions when you encounter serial lesions or diffuse disease. Hyperemia-free iFR Scout makes assessing physiology before, during, and after your procedure easier.
Providing choice
Providing choice
Switch between iFR and FFR seamlessly. Bedside-integrated and mobile configurations provide flexibility.
Providing choice
Switch between iFR and FFR seamlessly. Bedside-integrated and mobile configurations provide flexibility.
Providing choice
Switch between iFR and FFR seamlessly. Bedside-integrated and mobile configurations provide flexibility.
The iFR modality has been studied in over 9,000 patients, and large iFR outcome trials have enrolled 5,000 patients.¹ Additionally, numerous prospective iFR studies have been published in peer-reviewed journals showing its significance in assisting lesion assessment.
Clinical progress
The iFR modality has been studied in over 9,000 patients, and large iFR outcome trials have enrolled 5,000 patients.¹ Additionally, numerous prospective iFR studies have been published in peer-reviewed journals showing its significance in assisting lesion assessment.
Clinical progress
The iFR modality has been studied in over 9,000 patients, and large iFR outcome trials have enrolled 5,000 patients.¹ Additionally, numerous prospective iFR studies have been published in peer-reviewed journals showing its significance in assisting lesion assessment.
The iFR modality has been studied in over 9,000 patients, and large iFR outcome trials have enrolled 5,000 patients.¹ Additionally, numerous prospective iFR studies have been published in peer-reviewed journals showing its significance in assisting lesion assessment.
iFR Scout
iFR Scout Pullback technology
iFR Scout pullback technology provides the physiologic profile of the entire vessel, helping you make informed treatment decisions when you encounter serial lesions or diffuse disease. Hyperemia-free iFR Scout makes assessing physiology before, during, and after your procedure easier.
iFR Scout Pullback technology
iFR Scout pullback technology provides the physiologic profile of the entire vessel, helping you make informed treatment decisions when you encounter serial lesions or diffuse disease. Hyperemia-free iFR Scout makes assessing physiology before, during, and after your procedure easier.
iFR Scout Pullback technology
iFR Scout pullback technology provides the physiologic profile of the entire vessel, helping you make informed treatment decisions when you encounter serial lesions or diffuse disease. Hyperemia-free iFR Scout makes assessing physiology before, during, and after your procedure easier.
iFR Scout pullback technology provides the physiologic profile of the entire vessel, helping you make informed treatment decisions when you encounter serial lesions or diffuse disease. Hyperemia-free iFR Scout makes assessing physiology before, during, and after your procedure easier.
Providing choice
Providing choice
Switch between iFR and FFR seamlessly. Bedside-integrated and mobile configurations provide flexibility.
Providing choice
Switch between iFR and FFR seamlessly. Bedside-integrated and mobile configurations provide flexibility.
Providing choice
Switch between iFR and FFR seamlessly. Bedside-integrated and mobile configurations provide flexibility.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
Κάνοντας κλικ στον σύνδεσμο, θα φύγετε από τον επίσημο ιστότοπο της Philips Electronics Ltd. ("Philips"). Τυχόν σύνδεσμοι προς ιστότοπους τρίτων που ενδέχεται να εμφανίζονται σε αυτόν τον ιστότοπο παρέχονται μόνο για τη διευκόλυνσή σας και σε καμία περίπτωση δεν αντιπροσωπεύουν οποιαδήποτε σχέση ή έγκριση των πληροφοριών που παρέχονται σε αυτούς τους συνδεδεμένους ιστότοπους. Η Philips δεν προβαίνει σε δηλώσεις ή εγγυήσεις κανενός είδους σχετικά με ιστότοπους τρίτων ή τις πληροφορίες που περιέχονται σε αυτούς.
